Targeted Clinical Cancer Trials

Where can I find information about clinical trials of targeted therapies?

What is Clinical Research?

  • What is Clinical Research?

    • Clinical Research is a mechanism through which we can find new modalities of treatment where the standard of care has exhausted the current ways to treat these types of cancers.

  • When are Clinical Trials Recommended for patients?

    • Clinical trials are mostly recommended to patients after the standard-of-care options have been exhausted.
    • Our center for clinical trials is obligated to access standard-of-care treatment options for our patients before recommending clinical trials.
    • When a patient does not have any treatment options available on the market, clinical trials are the only option as new medicine is only available through clinical research.

  • Are Clinical Trials Safe?

    • All our clinical trials that are open to enrollment have been conducted on humans and have safety data available.
    • The conduct of clinical trials is well organized, scrutinized, and secured by a team of clinical providers who assess and closely monitor the participants prior to study enrollment and throughout the study, and follow up with participants after their participation to ensure their safety.

  • Why Participate in Clinical Trials?

    • Through clinical trials, you will have access to medical treatments that have not been provided to the general population.
    • Clinical trials can give study participants an opportunity to use medicine that they would otherwise not have access to prior to its approval. This opportunity could be the solution for your condition when nothing else is working.

  • Do I Have to Pay to Participate and Does My Insurance Cover the Expenses?

    • Study participants receive study-related care at no cost.
    • Insurance is not required.
    • You will be compensated for your time, travel, and study-related expenses.
    • Transportation can be arranged at no cost to you if needed.

  • What if I Change My Mind After Enrolling?

    • Should you choose to discontinue your participation in the study, you are free to opt out at any time, for any reason without penalties.

  • Can I Continue Taking the Study Treatment After the Trial Ends?

    • Some clinical trials allow study participants to continue the same medication at no cost to them after the study ends as long as they are receiving clinical benefits from the study medicine.

  • What Types of Cancers and Blood Disorders are Covered by Clinical Trials?

    • Our Cancer Institute provides clinical trials for different types of tumors including lung cancer, prostate cancer, bladder cancer, kidney cancer, gastrointestinal cancer, liver cancer, lymphoma, central nervous system tumors, acute and chronic leukemia, bone marrow disorders, and uncommon hard-to-treat anemias.

For more information, please call our toll-free number (833) 330-0930 or contact us via email info@goodclinicaltrials.com 

Clinical Trials Brochure

Targeted Cancer Therapies Was Studied in Clinical Trials:

  • Alemtuzumab (Campath®)
  • Alitretinoin (Panretin®)
  • Anastrozole (Arimidex®)
  • Bevacizumab (Avastin®)
  • Bexarotene (Targretin®)
  • Bortezomib (Velcade®)
  • Cetuximab (Erbitux®)
  • Dasatinib (Sprycel®)
  • Denileukin diftitox (Ontak®)
  • Erlotinib hydrochloride (Tarceva®)
  • Everolimus (Afinitor®)
  • Exemestane (Aromasin®)
  • Fulvestrant (Faslodex®)
  • Gefitinib (Iressa®)
  • Ibritumomab tiuxetan (Zevalin®)
  • Imatinib mesylate (Gleevec®)
  • Lapatinib ditosylate (Tykerb®)
  • Letrozole (Femara®)
  • Nilotinib (Tasigna®)
  • Ofatumumab (Arzerra®)
  • Panitumumab (Vectibix®)
  • Pazopanib hydrochloride (Votrient®)
  • Pralatrexate (Folotyn®)
  • Rituximab (Rituxan®)
  • Romidepsin (Istodax®)
  • Sorafenib tosylate (Nexavar®)
  • Sunitinib malate (Sutent®)
  • Tamoxifen
  • Temsirolimus (Torisel®)
  • Toremifene (Fareston®)
  • Tositumomab and 131I-tositumomab (Bexxar®)
  • Trastuzumab (Herceptin®)
  • Tretinoin (Vesanoid®)
  • Vorinostat (Zolinza®)

Head and Neck Cancer Clinical Trial

If you or a family member 18 years of age or older has been diagnosed with cancer of the throat or mouth, you may qualify for a clinical trial and will receive study treatment and compensation.  Please click on the link below for more information:

Multiple Myeloma:

We are enrolling participants 18 and older in a clinical study for Multiple Myeloma. To qualify, you must:


  • Have been diagnosed with Multiple Myeloma
  • Have received at least 1 prior line of anti-myeloma therapy
  • Have documented evidence of progressive disease on or after the last regimen


Participants may receive compensation and study treatment.


Please contact us for more information.

Click Here

Chronic Myeloid Leukemia (CML)

If you are 18 years of age or older and have been newly diagnosed with Chronic Myeloid Leukemia or have received prior treatment with imatinib, or nilotinib, or dasatinib or bosutinib for 4 weeks or less, you may qualify for a clinical study.


Participants may receive compensation and study treatment.


Please contact us for more information.

Click Here

Contact Us Today:


Located: 3465 Nazareth Road, Suite 102 Easton, PA 18045

Phone: (833) 330-0930

Text: 717-819-9982

Email: info@goodclinicaltrials.com

Share by: